FEBS Journal,
Journal Year:
2024,
Volume and Issue:
unknown
Published: March 1, 2024
Huntington's
disease
(HD)
is
a
currently
incurable
neurogenerative
disorder
and
typically
characterized
by
progressive
movement
(including
chorea),
cognitive
deficits
(culminating
in
dementia),
psychiatric
abnormalities
(the
most
common
of
which
depression),
peripheral
symptoms
gastrointestinal
dysfunction).
There
are
no
approved
disease‐modifying
therapies
available
for
HD,
with
death
usually
occurring
approximately
10–25
years
after
onset,
but
some
hold
promising
potential.
HD
subjects
often
burdened
chronic
diarrhea,
constipation,
esophageal
gastric
inflammation,
susceptibility
to
diabetes.
Our
understanding
the
microbiota–gut–brain
axis
its
infancy
growing
evidence
from
preclinical
clinical
studies
suggests
role
gut
microbial
population
imbalance
(gut
dysbiosis)
pathophysiology.
The
brain
can
communicate
through
enteric
nervous
system,
immune
vagus
nerve,
microbiota‐derived‐metabolites
including
short‐chain
fatty
acids,
bile
branched‐chain
amino
acids.
This
review
summarizes
supporting
demonstrating
alterations
bacterial
fungal
composition
that
may
be
associated
HD.
We
focus
on
mechanisms
dysbiosis
compromise
health,
thus
triggering
neuroinflammatory
responses,
further
highlight
outcomes
attempts
modulate
microbiota
as
therapeutic
strategies
Ultimately,
we
discuss
dearth
data
need
more
longitudinal
translational
this
nascent
field.
suggest
future
directions
improve
our
association
between
microbes
pathogenesis
other
‘brain
body
disorders’.
Science China Life Sciences,
Journal Year:
2016,
Volume and Issue:
59(10), P. 1006 - 1023
Published: Aug. 26, 2016
Alzheimer's
disease
(AD)
is
a
most
common
neurodegenerative
disorder,
which
associates
with
impaired
cognition.
Gut
microbiota
can
modulate
host
brain
function
and
behavior
via
microbiota-gut-brain
axis,
including
cognitive
behavior.
Germ-free
animals,
antibiotics,
probiotics
intervention
diet
induce
alterations
of
gut
physiology
also
behavior,
increasing
or
decreasing
risks
AD.
The
increased
permeability
intestine
blood-brain
barrier
induced
by
disturbance
will
increase
the
incidence
neurodegeneration
disorders.
microbial
metabolites
their
effects
on
neurochemical
changes
may
decrease
risk
Pathogenic
microbes
infection
AD,
meanwhile,
onset
AD
support
"hygiene
hypothesis".
All
results
suggest
that
begin
in
gut,
closely
related
to
imbalance
microbiota.
Modulation
through
personalized
beneficial
probably
become
new
treatment
for
Frontiers in Immunology,
Journal Year:
2018,
Volume and Issue:
8
Published: Jan. 24, 2018
In
recent
years,
many
paradigms
concerning
central
nervous
system
(CNS)
immunology
have
been
challenged
and
shifted,
including
the
discovery
of
CNS-draining
lymphatic
vessels,
origin
functional
diversity
microglia,
impact
T
cells
on
CNS
immunological
homeostasis
role
neuroinflammation
in
neurodegenerative
diseases.
parallel,
antigen
presentation
outside
has
revealed
vital
antigen-presenting
maintaining
tolerance
toward
self-proteins,
thwarting
auto-immunity.
Here,
we
review
findings
that
unite
these
shifted
microglial
functioning,
presentation,
CNS-directed
cell
activation,
focusing
common
It
provides
an
important
update
adaptive
immunity,
novel
targets,
a
concept
microglia
T-cell
equilibrium.
Frontiers in Aging Neuroscience,
Journal Year:
2017,
Volume and Issue:
9
Published: June 20, 2017
The
neurological
deterioration
associated
with
Alzheimer’s
disease,
involving
accumulation
of
amyloid-beta
peptides
and
neurofibrillary
tangles,
is
evident
neuroinflammation.
This
now
seen
to
be
a
significant
contributor
pathology.
Recently
the
tenet
privileged
status
brain,
regarding
microbial
compromise,
has
been
questioned,
particularly
in
terms
neurodegenerative
diseases.
It
being
considered
that
microbiological
incursion
into
central
nervous
system
could
either
an
initiator
or
these.
novel
study
using
16S
ribosomal
gene-specific
Next
Generation
Sequencing
extracted
brain
tissue.
A
comparison
was
made
bacterial
species
content
both
frozen
formaldehyde
fixed
sections
small
cohort
Alzheimer-affected
cases
those
cognitively
unimpaired
(normal).
Our
findings
suggest
increase
populations
Alzheimer
tissue
compared
normal.
Frontiers in Aging Neuroscience,
Journal Year:
2018,
Volume and Issue:
10
Published: April 25, 2018
Amyloid-ß
(Aß)
is
best
known
as
the
misfolded
peptide
that
involved
in
pathogenesis
of
Alzheimer's
disease
(AD),
and
it
currently
primary
therapeutic
target
attempts
to
arrest
course
this
disease.
This
notoriety
has
overshadowed
evidence
Aß
serves
several
important
physiological
functions.
present
throughout
lifespan,
been
found
all
vertebrates
examined
thus
far,
its
molecular
sequence
shows
a
high
degree
conservation.
These
features
are
typical
factor
contributes
significantly
biological
fitness,
suggestion
supported
by
functions
beneficial
for
brain.
The
putative
roles
include
protecting
body
from
infections,
repairing
leaks
blood-brain
barrier,
promoting
recovery
injury,
regulating
synaptic
function.
Evidence
these
comes
vitro
vivo
studies,
which
have
shown
cellular
production
rapidly
increases
response
challenge
often
diminishes
upon
recovery.
further
adverse
outcomes
clinical
trials
attempted
deplete
order
treat
AD.
We
suggest
anti-Aß
therapies
will
produce
fewer
effects
if
triggers
deposition
(e.g.
pathogens,
hypertension
diabetes)
addressed
first.
Alzheimer s Research & Therapy,
Journal Year:
2017,
Volume and Issue:
9(1)
Published: March 3, 2017
Previously,
the
contribution
of
peripheral
infection
to
cognitive
decline
was
largely
overlooked
however,
past
15
years
have
established
a
key
role
for
infectious
pathogens
in
progression
age-related
neurodegeneration.
It
is
now
accepted
that
immune
privilege
brain
not
absolute,
and
cells
central
nervous
system
are
sensitive
both
inflammatory
events
occurring
periphery
infiltration
cells.
This
particularly
relevant
Alzheimer's
disease,
which
it
has
been
demonstrated
patients
more
vulnerable
infection-related
changes.
can
occur
from
typical
challenges
such
as
respiratory
tract
infections,
although
number
specific
viral,
bacterial,
fungal
also
associated
with
development
disease.
To
date,
clear
whether
these
microorganisms
directly
related
disease
or
if
they
opportune
easily
colonize
those
dementia
exacerbate
ongoing
inflammation
observed
individuals.
review
will
discuss
impact
each
challenges,
examine
changes
known
age
system,
may
contribute
vulnerability
infection-induced
decline.
CNS Drugs,
Journal Year:
2017,
Volume and Issue:
31(12), P. 1057 - 1082
Published: Dec. 1, 2017
Over
the
past
few
decades,
research
on
Alzheimer's
disease
(AD)
has
focused
pathomechanisms
linked
to
two
of
major
pathological
hallmarks
extracellular
deposition
beta-amyloid
peptides
and
intra-neuronal
formation
neurofibrils.
Recently,
a
third
component,
neuroinflammatory
reaction
mediated
by
cerebral
innate
immune
cells,
entered
spotlight,
prompted
findings
from
genetic,
pre-clinical,
clinical
studies.
Various
proteins
that
arise
during
neurodegeneration,
including
beta-amyloid,
tau,
heat
shock
proteins,
chromogranin,
among
others,
act
as
danger-associated
molecular
patterns,
that—upon
engagement
pattern
recognition
receptors—induce
inflammatory
signaling
pathways
ultimately
lead
production
release
mediators.
These
may
have
beneficial
effects
but
compromise
neuronal
function
cause
cell
death.
The
current
review,
assembled
participants
Chiclana
Summer
School
Neuroinflammation
2016,
provides
an
overview
our
understanding
AD-related
processes.
We
describe
principal
cellular
players
in
inflammation
they
pertain
AD,
examine
modifying
factors,
discuss
potential
future
therapeutic
targets.
Brain Behavior and Immunity,
Journal Year:
2017,
Volume and Issue:
65, P. 350 - 361
Published: June 11, 2017
A
number
of
clinical
and
experimental
studies
have
revealed
a
strong
association
between
periodontitis
accelerated
cognitive
decline
in
Alzheimer’s
disease
(AD);
however,
the
mechanism
is
unknown.
In
present
study,
we
tested
hypothesis
that
cathepsin
(Cat)
B
plays
critical
role
initiation
neuroinflammation
neural
dysfunction
following
chronic
systemic
exposure
to
lipopolysaccharide
from
Porphyromonas
gingivalis
(PgLPS)
mice
(1
mg/kg,
daily,
intraperitoneally).
Young
(2
months
old)
middle-aged
(12
wild-type
(WT;
C57BL/6N)
or
CatB-deficient
(CatB−/−)
were
exposed
PgLPS
daily
for
5
consecutive
weeks.
The
learning
memory
function
assessed
using
passive
avoidance
test,
expression
amyloid
precursor
protein
(APP),
CatB,
TLR2
IL-1β
was
analyzed
brain
tissues
by
immunohistochemistry
Western
blotting.
We
found
five
weeks
induced
deficits
with
intracellular
accumulation
Aβ
neurons
WT
mice,
but
not
young
CatB−/−
mice.
significantly
increased
CatB
both
microglia
while
mature
restricted
hippocampus
ones.
vitro
studies,
µg/ml)
stimulation
upregulated
mean
mRNA
IL-1β,
downregulated
levels
IκBα
cultured
MG6
as
well
primary
which
inhibited
CatB-specific
inhibitor
CA-074Me
Furthermore,
APP
hippocampal
after
treatment
conditioned
medium
PgLPS-treated
microglia,
neutralized
anti-IL-1beta,
directly.
Taken
together,
these
findings
indicate
induces
AD-like
phenotypes,
including
microglia-mediated
neuroinflammation,
impairment
functions
CatB-dependent
manner.
propose
may
be
therapeutic
target
preventing
periodontitis-associated
AD.
Journal of Alzheimer s Disease,
Journal Year:
2018,
Volume and Issue:
62(4), P. 1495 - 1506
Published: Feb. 28, 2018
The
amyloid-β
(Aβ)
peptide
has
long
been
considered
to
be
the
driving
force
behind
Alzheimer’s
disease
(AD).
However,
clinical
trials
that
have
successfully
reduced
Aβ
burden
in
brain
not
slowed
cognitive
decline,
and
some
instances,
resulted
adverse
outcomes.
While
these
results
can
interpreted
different
ways,
a
more
nuanced
picture
of
is
emerging
takes
into
account
facts
evolutionarily
conserved
present
throughout
life
cognitively
normal
individuals.
Recent
evidence
indicates
role
for
as
an
antimicrobial
(AMP),
class
innate
immune
defense
molecule
utilizes
fibrillation
protect
host
from
wide
range
infectious
agents.
In
humans
animal
models,
infection
frequently
leads
increased
amyloidogenic
processing
protein
precursor
(AβPP)
resultant
fibrillary
aggregates
Aβ.
Evidence
vitro
vivo
studies
demonstrates
oligomers
potent,
broad-spectrum
properties
by
forming
fibrils
entrap
pathogens
disrupt
cell
membranes.
Importantly,
overexpression
confers
resistance
both
bacteria
viruses.
may
explain
why
rates
observed
AD
depleted
Perhaps
progress
toward
cure
will
accelerate
once
treatment
strategies
begin
take
likely
physiological
functions
this
enigmatic
peptide.